Navigation Links
SuperGen to Webcast 3rd Annual Analyst Day on April 29, 2008

DUBLIN, Calif., April 22 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, invites all interested parties to listen and view a live webcast of its 3rd Annual Analyst Day beginning at 9:30 a.m. ET (6:30 a.m. PT) to approximately 12:00 p.m. ET (9:00 a.m. PT) on Tuesday, April 29, 2008.

Investors and interested parties may access the webcast via the Investor Relations homepage of SuperGen's Web site at A webcast replay will be available for 90 days following the live event.

About SuperGen

Based in Dublin, Calif., SuperGen Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit


SuperGen, Inc.

Timothy L. Enns

S.V.P., Corporate Communications & Business Development

(925) 560-0100

SuperGen, Inc.

Mary M. Vegh

Manager, Investor Relations

(925) 560-2845

SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
2. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
3. SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008
4. SuperGen Reports 2007 Fourth Quarter and Annual Financial Results
5. SuperGen to Announce 2008 First Quarter Financial Results April 28, 2008
6. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
7. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
8. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
9. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
Post Your Comments:
(Date:10/7/2015)... --  PDI , a leader in infection prevention products ... challenges across various healthcare settings, as well as guidelines ... tool is part of a larger effort to raise ... and lower healthcare-associated infections. ... how to use the right product, in the right ...
(Date:10/7/2015)... RADNOR, Pa. , Oct. 7, 2015   ... global, independent provider of laboratory products, services and ... Technologies Inc. (PTI), a specialty solvent company that ... solvents. This acquisition will enhance VWR,s growing laboratory ... its laboratory and biopharmaceutical manufacturing customers. ...
(Date:10/7/2015)... Clara, CA (PRWEB) , ... October 07, 2015 ... ... microscopy (AFM) today announced a webinar titled Smart Nanostructured Coatings to provide a ... 15, 2015. Register for this free webinar at . This webinar ...
(Date:10/7/2015)... ... October 07, 2015 , ... Optivia ... to develop a dynamic, multi-scale, physiologically based pharmacokinetic (dmPBPK) modeling platform for predicting ... combine their respective expertise in in vitro transporter assay technology and modeling methods ...
Breaking Biology Technology:
... NEW YORK , May 28 /PRNewswire-Asia-FirstCall/ ... international biopharmaceutical company,with operations in the U.S. and China , announced ... BSN, RN, HP (ASCP), has been,selected to present at the American Society ... , , , ...
... 27 Celsis International, the global leader in rapid ... the U.S. Food & Drug Administration (FDA) to include information on testing ... the Celsis system. , , ... growing number of our Rapid Detection customers are using their Celsis systems ...
... NewLink Genetics Corporation announced today treatment of the first patient ... for patients who have successfully undergone pancreatic surgical resection. , ... "This pivotal study represents one of ... cancer in the United States ," said Charles Link , ...
Cached Biology Technology:
(Date:9/29/2015)... is excited to be named one of the first 100 ... announcement was recently made at an invite-only IBM Watson: ... Francisco , where iDAvatars presented a demo of its ... "It is both an honor and a privilege to be ... the cognitive power of IBM Watson in our product, which ...
(Date:9/28/2015)... 28, 2015 Synaptics Inc. (NASDAQ: SYNA ... announced that Lenovo has selected Synaptics , Natural ... its latest smartphone, the Vibe P1. The new ... the device and provide swift access to applications and ... Natural ID FS4202 sensor solution utilizes AES256-bit encryption of ...
(Date:9/10/2015)... , Sept. 10, 2015 Report Details ... Study Reveals Selling Opportunities and Revenue Prospects to ... future of biologics, especially new drug classes? Get ... stay ahead with exclusive market data and industry ... trends, developments, results, opportunities and sales predictions. ...
Breaking Biology News(10 mins):
... WASHINGTON, DC -- June 2, 2011 -- A ... (MRSA) that is not detected by traditional genetic ... hospitals according to research to be published in the ... provide significant insights into how new MRSA strains emerge ...
... On June 9-10, Stevens Institute of Technology ... an event that covers the latest multi-disciplinary research ... dinner keynote from Dr. J. William Costerton, a ... will confront important issues and questions at the ...
... Scientists have identified a drug combination, when used in advanced ... no longer respond to existing therapies. They found that bexarotene ... cyclin D1. The drug combination also broadened the reach to ... due to the presence of a ras mutation in their ...
Cached Biology News:
Rabbit polyclonal to HMGB1 (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 3146 SwissProtID: P09429...
Pooled normal sreum with 0.1% sodium azide as preservative...
Mouse CXCR3 Allophycocyanin MAb (Clone 220803)...
Mouse P-Selectin/CD62P MAb (Clone 127933)...
Biology Products: